CN111529632A - Traditional Chinese medicine formula for treating infantile epistaxis and preparation method thereof - Google Patents
Traditional Chinese medicine formula for treating infantile epistaxis and preparation method thereof Download PDFInfo
- Publication number
- CN111529632A CN111529632A CN202010420499.7A CN202010420499A CN111529632A CN 111529632 A CN111529632 A CN 111529632A CN 202010420499 A CN202010420499 A CN 202010420499A CN 111529632 A CN111529632 A CN 111529632A
- Authority
- CN
- China
- Prior art keywords
- parts
- group
- chinese medicine
- traditional chinese
- epistaxis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
- A61K36/515—Gentiana
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/538—Schizonepeta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine formula for treating infantile epistaxis, which comprises the following raw materials in parts by weight: group A: 50-80 parts of bletilla striata, 50-75 parts of scutellaria baicalensis, 20-50 parts of gentian, 10-30 parts of raw liquorice, 70-100 parts of fried lotus node and 70-100 parts of fried sophora flower; group B: 80-100 parts of cogongrass rhizome, 50-65 parts of red peony root, 50-65 parts of moutan bark, 50-65 parts of gardenia jasminoides, 110-140 parts of hairyvein agrimony and 60-90 parts of herba nonanthi praeparata; group C: 20-50 parts of Senecio cannabifolius less, 50-80 parts of Japanese thistle herb, 50-80 parts of white mulberry root-bark, 40-70 parts of carbonized human hair, 50-65 parts of cacumen biotae, 20-35 parts of rheum officinale and 50-80 parts of radix ophiopogonis; group D: 50-65 parts of callicarpa bodinieri, 70-100 parts of clinopodium polycephalum, 50-65 parts of euphorbia hirta, 70-110 parts of charred schizonepeta, 50-65 parts of charred cattail pollen and 70-100 parts of charred madder. The formula has no adverse reaction and side effect, no dependence, safety and reliability, and no recurrence.
Description
Technical Field
The invention relates to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine formula for treating infantile epistaxis and a preparation method thereof.
Background
The infantile epistaxis refers to nasal bleeding caused by rupture of blood vessels in nasal cavity, nasal sinuses or nasopharynx, and is a common symptom, and mild cases are bloody nasal discharge or punctate blood drops. In severe cases, massive hemorrhage is not easy to control, and hemorrhagic shock can be caused. According to incomplete statistics, nearly 0.5-1% of children aged 2-10 years in China have symptoms of excessive nosebleed, so that parents of many children feel very vexation, most commonly used for quickly treating the nosebleed of the children at present is the chlorphenamine, and although the chlorphenamine takes effect quickly, the chlorphenamine takes temporary symptoms instead of permanent symptoms, and is easy to relapse.
According to our knowledge, no Chinese patent medicine specially used for treating the nosebleed of teenagers is found in the market of China, which is exactly regret. Therefore, the method for treating epistaxis by using the traditional Chinese medicine is very important.
Disclosure of Invention
One of the objects of the present invention is: provides a traditional Chinese medicine formula with good effect and difficult recurrence for treating the epistaxis of children.
In order to achieve the above purpose, the invention provides the following technical scheme:
a traditional Chinese medicine formula for treating infantile epistaxis comprises the following raw materials in parts by weight:
group A: 50-80 parts of bletilla striata, 50-75 parts of scutellaria baicalensis, 20-50 parts of gentian, 10-30 parts of raw liquorice, 70-100 parts of fried lotus node and 70-100 parts of fried sophora flower;
group B: 80-100 parts of cogongrass rhizome, 50-65 parts of red peony root, 50-65 parts of moutan bark, 50-65 parts of gardenia jasminoides, 110-140 parts of hairyvein agrimony and 60-90 parts of herba nonanthi praeparata;
group C: 20-50 parts of Senecio cannabifolius less, 50-80 parts of Japanese thistle herb, 50-80 parts of white mulberry root-bark, 40-70 parts of carbonized human hair, 50-65 parts of cacumen biotae, 20-35 parts of rheum officinale and 50-80 parts of radix ophiopogonis;
group D: 50-65 parts of callicarpa bodinieri, 70-100 parts of clinopodium polycephalum, 50-65 parts of euphorbia hirta, 70-110 parts of schizonepeta charcoal, 50-65 parts of cattail pollen charcoal and 70-100 parts of India madder root charcoal;
wherein, the weight ratio of the group A, the group B, the group C and the group D is 1: 1: 1: 1.
preferably, the traditional Chinese medicine formula for treating infantile epistaxis comprises the following raw materials in parts by weight:
group A: 60-70 parts of bletilla striata, 60-70 parts of scutellaria baicalensis, 30-40 parts of gentian, 20-30 parts of raw liquorice, 80-90 parts of fried lotus rhizome node and 80-90 parts of fried sophora flower;
group B: 90-100 parts of cogongrass rhizome, 55-60 parts of red peony root, 60-65 parts of tree peony bark, 55-60 parts of gardenia jasminoides, 120 parts of hairyvein agrimony, 130 parts of red sage herb and 70-80 parts of common clubmoss herb;
group C: 30-40 parts of Senecio cannabifolius less, 60-70 parts of Japanese thistle herb, 60-70 parts of white mulberry root-bark, 50-60 parts of carbonized human hair, 55-60 parts of cacumen biotae, 25-30 parts of rhubarb and 60-70 parts of dwarf lilyturf tuber;
group D: 55-60 parts of callicarpa bodinieri, 80-90 parts of clinopodium polycephalum, 55-60 parts of euphorbia hirta, 80-100 parts of charred schizonepeta, 55-60 parts of charred cattail pollen and 80-90 parts of charred madder;
wherein, the weight ratio of the group A, the group B, the group C and the group D is 1: 1: 1: 1.
preferably, the traditional Chinese medicine formula for treating infantile epistaxis comprises the following raw materials in parts by weight:
group A: 65 parts of bletilla striata, 65 parts of scutellaria baicalensis, 35 parts of gentian, 26 parts of raw liquorice, 85 parts of fried lotus rhizome node and 85 parts of fried sophora flower;
group B: 95 parts of cogongrass rhizome, 58 parts of radix paeoniae rubra, 62 parts of cortex moutan radicis, 58 parts of gardenia jasminoides, 125 parts of agrimony and 75 parts of herba nonanthi;
group C: 35 parts of Senecio cannabifolius less, 66 parts of Japanese thistle herb, 65 parts of white mulberry root-bark, 55 parts of carbonized human hair, 57 parts of cacumen biotae, 28 parts of rhubarb and 66 parts of dwarf lilyturf tuber;
group D: 58 parts of callicarpa bodinieri, 85 parts of clinopodium polycephalum, 57 parts of euphorbia hirta, 90 parts of schizonepeta charcoal, 57 parts of cattail pollen charcoal and 85 parts of India madder root charcoal;
wherein, the weight ratio of the group A, the group B, the group C and the group D is 1: 1: 1: 1.
the second purpose of the invention is: provides a preparation method of a traditional Chinese medicine formula for treating infantile epistaxis.
In order to achieve the above purpose, the invention provides the following technical scheme:
a preparation method of a traditional Chinese medicine formula for treating infantile epistaxis comprises the following specific steps:
(1) weighing the raw materials according to the weight parts, uniformly mixing, and putting into a health preserving pot or a marmite for later use;
(2) adding water, soaking, decocting, and filtering to obtain filtrate.
Preferably, the amount of water added in step (2) is 5-8 times the weight of the raw materials.
Preferably, the amount of water added in step (2) is 6 times the weight of the raw materials.
Preferably, the soaking time in the step (2) is 3-5 h.
Preferably, the soaking time in step (2) is 4 h.
Preferably, the decocting time in the step (2) is 1-2 h.
Preferably, the decocting time in step (2) is 1.5 h.
The main effects of the raw materials used in the traditional Chinese medicine formula are as follows:
bletilla striata has the effects of astringing to stop bleeding, relieving swelling and promoting tissue regeneration; can be used for treating hemoptysis, hematemesis, traumatic hemorrhage, pyocutaneous disease, toxic swelling, and chapped skin; pulmonary tuberculosis hemoptysis, ulcer hemorrhage.
Scutellaria baicalensis: has effects in clearing away heat, eliminating dampness, purging pathogenic fire, removing toxic materials, stopping bleeding, and preventing miscarriage; it can be used for treating epidemic febrile disease, upper respiratory infection, cough due to lung heat, yellow gallbladder due to damp-heat, pneumonia, dysentery, hemoptysis, conjunctival congestion, threatened abortion, hypertension, carbuncle, furuncle, and sore.
Gentian: has the effects of clearing heat, eliminating dampness and purging liver and gallbladder fire; can be used for treating jaundice due to damp-heat pathogen, pudendal swelling, pudendal pruritus, eczema, pruritus, liver fire, conjunctival congestion, tinnitus, deafness, hypochondriac pain, bitter taste in mouth, middle-jiao strengthening, and convulsion.
Raw licorice root: benefiting qi and invigorating middle warmer; relieving spasm and pain; moistening lung to arrest cough; purging pathogenic fire and removing toxic substances; harmonizing the effects of the various drugs; mainly treats the symptoms of listlessness and poor appetite; emaciation and yellow face; palpitation and shortness of breath; abdominal pain and loose stool; limb spasm and pain; irritability; cough and asthma; swollen and sore throat; carbuncle sore and swelling pain; infantile carbuncle is caused.
Frying lotus rhizome nodes: has the effects of astringing to stop bleeding and removing blood stasis, and is mainly used for hematemesis, hemoptysis, epistaxis, hematuria and metrorrhagia and metrostaxis.
And (3) frying the sophora flower: has effects of clearing away heat and toxic materials, cooling blood, moistening lung, lowering blood pressure, and preventing apoplexy.
Cogongrass rhizome: has the effects of cooling blood, stopping bleeding, clearing heat and promoting urination; can be used for treating hematemesis due to blood heat, epistaxis, hematuria, fever polydipsia, cough due to lung heat, stomach heat emesis, jaundice due to damp-heat pathogen, edema oliguria, stranguria with astringency and pain due to heat.
Radix paeoniae rubra: has the effects of clearing heat, cooling blood, removing blood stasis and relieving pain; it can be used for treating amenorrhea due to stasis, hernia, abdominal mass, abdominal pain, hypochondriac pain, epistaxis, dysentery with bloody stool, hematochezia, conjunctival congestion, carbuncle, swelling, and traumatic injury.
Moutan bark: has the effects of clearing heat and cooling blood, promoting blood circulation and removing blood stasis, and relieving deficiency heat.
Yellow gardenia: has the effects of clearing heat, purging fire and cooling blood.
Agrimony: has effects in astringing, stopping bleeding, relieving inflammation, relieving dysentery, removing toxic materials, killing parasite, invigorating qi, and tonifying heart; can be used for treating hematemesis, hemoptysis, epistaxis, hematuria, functional metrorrhagia, dysentery, gastroenteritis, trichomonas vaginalis, fatigue, asthenia, and contusion of lumbago.
Nine-tower grass: has the effects of dispelling wind, clearing heat, removing toxic substance, relieving swelling, and stopping bleeding; can be used for treating common cold, sunstroke, hepatitis, dysentery, enteritis, and external hemorrhage.
Herba Senecionis Cannabifolii: has the effects of warming lung, descending qi, eliminating phlegm and relieving cough; it can be used for treating cough and asthma due to wind-cold evil, cough with purulent blood, pharyngitis, and dysuresia.
And (5) common cephalanoplos herb: has the effects of cooling blood, stopping bleeding, removing blood stasis and relieving swelling; it can be used for treating epistaxis, hematemesis, hematuria, hematochezia, metrorrhagia, metrostaxis, traumatic hemorrhage, carbuncle, swelling, and skin ulcer.
White mulberry root-bark: has the effects of purging the lung, relieving asthma, promoting diuresis and relieving swelling; it can be used for treating cough and asthma due to lung heat, oliguria, edema, and swelling of skin.
Carbonized human hair: has the effects of astringing to stop bleeding, removing blood stasis and promoting urination; it can be used for treating hematemesis, hemoptysis, epistaxis, stranguria with blood, hematuria, hematochezia, metrorrhagia, traumatic hemorrhage, and dysuria.
Cacumen biotae: has the effects of cooling blood, stopping bleeding, eliminating phlegm, relieving cough, growing hair and blackening hair; can be used for treating hematemesis, epistaxis, hemoptysis, hematochezia, metrorrhagia, metrostaxis, cough due to lung heat, alopecia due to blood heat, and premature gray hair.
Rhubarb: has effects in eliminating stagnation, clearing away heat and dampness, purging pathogenic fire, cooling blood, removing blood stasis, and removing toxic materials; it can be used for treating constipation due to excessive heat accumulation, hematemesis, epistaxis, conjunctival congestion, pharyngeal swelling, carbuncle, furuncle, intestinal carbuncle, abdominal pain, amenorrhea due to blood stasis, puerperal blood stasis, traumatic injury, dysentery due to damp-heat pathogen, jaundice, dark urine, stranguria, and edema.
And (3) dwarf lilyturf root: has the effects of nourishing yin, moistening lung, benefiting stomach, promoting fluid production, clearing heart fire and relieving restlessness; can be used for treating dry cough due to lung dryness, lung carbuncle, cough due to yin deficiency, thirst due to body fluid consumption, diabetes, vexation, insomnia, throat pain, constipation due to intestinal dryness, hematemesis, and epistaxis.
Callicarpa bodinieri: has effects in dispelling blood stasis, stopping bleeding, relieving inflammation and pain, and inhibiting bacteria; it is used to treat hematemesis, hemoptysis, and hematochezia.
Blood flow breaking: has the effects of astringing and stopping bleeding; it can be used for treating metrorrhagia, metrostaxis, hematuria, epistaxis, gingival hemorrhage, and traumatic hemorrhage.
Flying poplar grass: has the effects of clearing away heat and toxic materials, promoting diuresis and relieving swelling; mainly treats pulmonary abscess; acute mastitis; dysentery; diarrhea; hot spraying; hematuria; eczema; tinea pedis; itch of the skin; furuncle swelling toxin; ulcerative gingivitis; and (5) lack of milk after delivery.
Charring the fineleaf schizonepeta herb: has the effects of astringing and stopping bleeding; it can be used for treating hematochezia, metrorrhagia, and puerperal blood dizziness.
Charring pollen Typhae: has the effects of promoting blood circulation, removing blood stasis and stopping bleeding; can be used for treating liver cancer due to accumulation of toxic heat and blood stasis, pancreatic cancer, biliary tract tumor, skin ecchymosis, gingival hemorrhage, dark urine, and greasy tongue coating.
Charring radix rubiae: has the effects of cooling blood, stopping bleeding, promoting blood circulation, removing blood stasis, dispelling pathogenic wind, dredging collaterals, clearing heat, removing jaundice, relieving cough and eliminating phlegm; can be used for treating hematemesis, epistaxis, hematuria, hematochezia, metrorrhagia, amenorrhea, rheumatalgia, traumatic injury, blood stasis, swelling and pain, jaundice, and chronic tracheitis.
The invention has the beneficial effects that:
the invention follows the prescription and medicament principle of the traditional Chinese medicine, carries out dialectical compatibility and prescription, selects bletilla striata, fried lotus rhizome node, fried sophora flower, hairyvein agrimony, charred schizonepeta, carbonized hair, clinopodium polycephalum and charred madder as monarch medicaments, and has the efficacy of astringing and stopping bleeding; the radix scutellariae, the gentian, the gardenia jasminoides ellis, the Cirsium japonicum, the cacumen biotae, the radix ophiopogonis, the rheum officinale, the callicarpa bodinieri, the cortex mori radicis and the cattail pollen charcoal are selected as ministerial drugs, so that the effect of guiding fire downward is achieved; cogongrass rhizome, garden euphorbia herb, red peony root, tree peony bark and herba nonanthi praeparata are selected as adjuvant drugs, so that the effects of removing stasis and cooling blood are achieved; licorice root and Senecio cannabifolius less are used as guiding drugs to harmonize the other drugs. The traditional Chinese medicine composition provided by the invention fundamentally cures the frequent epistaxis of children by combining the monarch, minister, assistant and guide medicines, has no adverse reaction, side effect, no dependence, safety, reliability and difficult recurrence.
DETAILED DESCRIPTION OF EMBODIMENT (S) OF INVENTION
Example 1
A traditional Chinese medicine formula for treating infantile epistaxis comprises the following raw materials in parts by weight:
group A: 50 parts of bletilla striata, 50 parts of scutellaria baicalensis, 20 parts of gentian, 10 parts of raw liquorice, 70 parts of fried lotus rhizome node and 70 parts of fried sophora flower;
group B: 80 parts of cogongrass rhizome, 50 parts of radix paeoniae rubra, 50 parts of cortex moutan radicis, 50 parts of gardenia jasminoides, 110 parts of hairyvein agrimony and 60 parts of herba nonanthi;
group C: 20 parts of Senecio cannabifolius less, 50 parts of Japanese thistle herb, 50 parts of white mulberry root-bark, 40 parts of carbonized human hair, 50 parts of cacumen biotae, 20 parts of rhubarb and 50 parts of dwarf lilyturf tuber;
group D: 50 parts of callicarpa bodinieri, 70 parts of clinopodium polycephalum, 50 parts of euphorbia hirta, 70 parts of schizonepeta charcoal, 50 parts of cattail pollen charcoal and 70 parts of madder charcoal;
wherein, the weight ratio of the group A, the group B, the group C and the group D is 1: 1: 1: 1.
the preparation method of the traditional Chinese medicine formula for treating infantile epistaxis comprises the following specific steps:
(1) weighing the raw materials according to the weight parts, uniformly mixing, and putting into a health preserving pot or a marmite for later use;
(2) adding 5 times of water by weight, soaking for 3h, decocting for 1h, and filtering to obtain filtrate.
Example 2
A traditional Chinese medicine formula for treating infantile epistaxis comprises the following raw materials in parts by weight:
group A: 80 parts of bletilla striata, 75 parts of scutellaria baicalensis, 50 parts of gentian, 30 parts of raw liquorice, 100 parts of fried lotus rhizome nodes and 100 parts of fried sophora japonica;
group B: 100 parts of cogongrass rhizome, 65 parts of radix paeoniae rubra, 65 parts of cortex moutan, 65 parts of gardenia jasminoides, 140 parts of hairyvein agrimony and 90 parts of herba nonanthi;
group C: 50 parts of Senecio cannabifolius less, 80 parts of Japanese thistle herb, 80 parts of white mulberry root-bark, 70 parts of carbonized human hair, 65 parts of cacumen biotae, 35 parts of rhubarb and 80 parts of dwarf lilyturf tuber;
group D: 65 parts of callicarpa bodinieri, 100 parts of clinopodium polycephalum, 65 parts of euphorbia hirta, 110 parts of schizonepeta charcoal, 65 parts of cattail pollen charcoal and 100 parts of India madder root charcoal;
wherein, the weight ratio of the group A, the group B, the group C and the group D is 1: 1: 1: 1.
the preparation method of the traditional Chinese medicine formula for treating infantile epistaxis comprises the following specific steps:
(1) weighing the raw materials according to the weight parts, uniformly mixing, and putting into a health preserving pot or a marmite for later use;
(2) adding 6 times of water by weight, soaking for 4h, decocting for 1.5h, and filtering to obtain filtrate.
Example 3
A traditional Chinese medicine formula for treating infantile epistaxis comprises the following raw materials in parts by weight:
group A: 60 parts of bletilla striata, 60 parts of scutellaria baicalensis, 30 parts of gentian, 20 parts of raw liquorice, 80 parts of fried lotus rhizome node and 80 parts of fried sophora flower;
group B: 90 parts of cogongrass rhizome, 55 parts of radix paeoniae rubra, 60 parts of cortex moutan, 55 parts of gardenia jasminoides, 120 parts of hairyvein agrimony and 70 parts of herba nonanthi;
group C: 30 parts of Senecio cannabifolius less, 60 parts of Japanese thistle herb, 60 parts of white mulberry root-bark, 50 parts of carbonized human hair, 55 parts of cacumen biotae, 25 parts of rhubarb and 60 parts of dwarf lilyturf tuber;
group D: 55 parts of callicarpa bodinieri, 80 parts of clinopodium polycephalum, 55 parts of euphorbia hirta, 80 parts of carbonized schizonepeta, 55 parts of carbonized cattail pollen and 80 parts of carbonized madder;
wherein, the weight ratio of the group A, the group B, the group C and the group D is 1: 1: 1: 1.
the preparation method of the traditional Chinese medicine formula for treating infantile epistaxis comprises the following specific steps:
(1) weighing the raw materials according to the weight parts, uniformly mixing, and putting into a health preserving pot or a marmite for later use;
(2) adding 8 times of water by weight, soaking for 5h, decocting for 2h, and filtering to obtain filtrate.
Example 4
A traditional Chinese medicine formula for treating infantile epistaxis comprises the following raw materials in parts by weight:
group A: 70 parts of bletilla striata, 70 parts of scutellaria baicalensis, 40 parts of gentian, 30 parts of raw liquorice, 90 parts of fried lotus rhizome nodes and 90 parts of fried sophora japonica;
group B: 100 parts of cogongrass rhizome, 60 parts of radix paeoniae rubra, 65 parts of cortex moutan, 60 parts of gardenia jasminoides, 130 parts of hairyvein agrimony and 80 parts of herba nonanthi;
group C: 40 parts of Senecio cannabifolius less, 70 parts of Japanese thistle herb, 70 parts of white mulberry root-bark, 60 parts of carbonized human hair, 60 parts of cacumen biotae, 30 parts of rhubarb and 70 parts of dwarf lilyturf tuber;
group D: 60 parts of callicarpa bodinieri, 90 parts of clinopodium polycephalum, 60 parts of euphorbia hirta, 100 parts of schizonepeta charcoal, 60 parts of cattail pollen charcoal and 90 parts of India madder root charcoal;
wherein, the weight ratio of the group A, the group B, the group C and the group D is 1: 1: 1: 1.
the preparation method of the traditional Chinese medicine formula for treating infantile epistaxis comprises the following specific steps:
(1) weighing the raw materials according to the weight parts, uniformly mixing, and putting into a health preserving pot or a marmite for later use;
(2) adding 7 times of water by weight, soaking for 5h, decocting for 2h, and filtering to obtain filtrate.
Example 5
A traditional Chinese medicine formula for treating infantile epistaxis comprises the following raw materials in parts by weight:
group A: 65 parts of bletilla striata, 65 parts of scutellaria baicalensis, 35 parts of gentian, 26 parts of raw liquorice, 85 parts of fried lotus rhizome node and 85 parts of fried sophora flower;
group B: 95 parts of cogongrass rhizome, 58 parts of radix paeoniae rubra, 62 parts of cortex moutan radicis, 58 parts of gardenia jasminoides, 125 parts of agrimony and 75 parts of herba nonanthi;
group C: 35 parts of Senecio cannabifolius less, 66 parts of Japanese thistle herb, 65 parts of white mulberry root-bark, 55 parts of carbonized human hair, 57 parts of cacumen biotae, 28 parts of rhubarb and 66 parts of dwarf lilyturf tuber;
group D: 58 parts of callicarpa bodinieri, 85 parts of clinopodium polycephalum, 57 parts of euphorbia hirta, 90 parts of schizonepeta charcoal, 57 parts of cattail pollen charcoal and 85 parts of India madder root charcoal;
wherein, the weight ratio of the group A, the group B, the group C and the group D is 1: 1: 1: 1.
the preparation method of the traditional Chinese medicine formula for treating infantile epistaxis comprises the following specific steps:
(1) weighing the raw materials according to the weight parts, uniformly mixing, and putting into a health preserving pot or a marmite for later use;
(2) adding 6 times of water by weight, soaking for 4h, decocting for 1.5h, and filtering to obtain filtrate.
And (3) clinical observation statistics:
1. observing an object:
the treated group and the control group have 100 cases respectively, and the age is between 2 and 10 years.
2. Method of treatment
Treatment groups: the medicine is taken three times a day after waiting for warm, 100mL is taken once, one treatment course is one week, and two to four weeks are used continuously.
Control group: hemostasis with chlorphenamine is adopted for bleeding.
3. Using recurrence time as therapeutic effect criterion
And (3) curing: the disease does not relapse within 1 year after hemostasis.
The method has the following advantages: the disease does not relapse within the second half year of hemostasis but relapses within 6-12 months.
And (4) invalidation: recurrence within half a year of hemostasis.
4. Results
The results are shown in table 1 below:
TABLE 1 therapeutic effect comparison table
Item | Cure of disease | Is effective | Invalidation |
Treatment group | 83 people | 11 persons | 6 persons |
Control group | 58 persons | 17 persons | 25 persons |
As can be seen from table 1: in 100 cases of the treatment group taking the medicine, 83 patients are cured, 11 patients are effective, and 6 patients are ineffective, the cure rate is 83%, and the total effective rate is 94%; in the control group, 58 patients are cured, 17 patients are effective, and 25 patients are not effective, the cure rate is 58%, and the total effective rate is 75%.
From the above data it can be seen that: when the method is adopted to treat the nasal bleeding with unknown reasons, the recurrence condition is obviously better than the haemostasis.
Examples of typical cases are:
case 1
The Chinese medicinal formula disclosed by the invention has the advantages that the patient can be cured after two treatment courses of treatment, the clinical symptoms completely disappear, and the disease does not relapse after one follow-up visit.
Case 2
Zhangxxx, female, 4 years old, school of kindergarten reading, 2016 for 5 months, in the school of activities outside class, collision with other children on duty, and fall down to cause epistaxis, the amount of bleeding is above 100ml, the infant is delivered to our place urgently, the traditional Chinese medicine is taken to be decocted and drenched, the epistaxis stops after one hour, and parents take three doses of traditional Chinese medicine advice to feed the infant at irregular time, so as to consolidate the treatment. After half a year follow-up, no recurrence occurs.
Case 3
Liao xxx, male, 6 years old, preschool scholars in kindergarten, from 3 years old, epistaxis in irregular time in day and night, parents of the students spend much on epistaxis treatment, and the epistaxis can not be cured radically by hospitalization and folk treatment.
Claims (10)
1. A traditional Chinese medicine formula for treating infantile epistaxis is characterized in that: the feed comprises the following raw materials in parts by weight:
group A: 50-80 parts of bletilla striata, 50-75 parts of scutellaria baicalensis, 20-50 parts of gentian, 10-30 parts of raw liquorice, 70-100 parts of fried lotus node and 70-100 parts of fried sophora flower;
group B: 80-100 parts of cogongrass rhizome, 50-65 parts of red peony root, 50-65 parts of moutan bark, 50-65 parts of gardenia jasminoides, 110-140 parts of hairyvein agrimony and 60-90 parts of herba nonanthi praeparata;
group C: 20-50 parts of Senecio cannabifolius less, 50-80 parts of Japanese thistle herb, 50-80 parts of white mulberry root-bark, 40-70 parts of carbonized human hair, 50-65 parts of cacumen biotae, 20-35 parts of rheum officinale and 50-80 parts of radix ophiopogonis;
group D: 50-65 parts of callicarpa bodinieri, 70-100 parts of clinopodium polycephalum, 50-65 parts of euphorbia hirta, 70-110 parts of schizonepeta charcoal, 50-65 parts of cattail pollen charcoal and 70-100 parts of India madder root charcoal;
wherein, the weight ratio of the group A, the group B, the group C and the group D is 1: 1: 1: 1.
2. the traditional Chinese medicine formula for treating epistaxis in children according to claim 1, which is characterized in that: the feed comprises the following raw materials in parts by weight:
group A: 60-70 parts of bletilla striata, 60-70 parts of scutellaria baicalensis, 30-40 parts of gentian, 20-30 parts of raw liquorice, 80-90 parts of fried lotus rhizome node and 80-90 parts of fried sophora flower;
group B: 90-100 parts of cogongrass rhizome, 55-60 parts of red peony root, 60-65 parts of tree peony bark, 55-60 parts of gardenia jasminoides, 120 parts of hairyvein agrimony, 130 parts of red sage herb and 70-80 parts of common clubmoss herb;
group C: 30-40 parts of Senecio cannabifolius less, 60-70 parts of Japanese thistle herb, 60-70 parts of white mulberry root-bark, 50-60 parts of carbonized human hair, 55-60 parts of cacumen biotae, 25-30 parts of rhubarb and 60-70 parts of dwarf lilyturf tuber;
group D: 55-60 parts of callicarpa bodinieri, 80-90 parts of clinopodium polycephalum, 55-60 parts of euphorbia hirta, 80-100 parts of charred schizonepeta, 55-60 parts of charred cattail pollen and 80-90 parts of charred madder;
wherein, the weight ratio of the group A, the group B, the group C and the group D is 1: 1: 1: 1.
3. the traditional Chinese medicine formula for treating epistaxis in children according to claim 2, which is characterized in that: the feed comprises the following raw materials in parts by weight:
group A: 65 parts of bletilla striata, 65 parts of scutellaria baicalensis, 35 parts of gentian, 26 parts of raw liquorice, 85 parts of fried lotus rhizome node and 85 parts of fried sophora flower;
group B: 95 parts of cogongrass rhizome, 58 parts of radix paeoniae rubra, 62 parts of cortex moutan radicis, 58 parts of gardenia jasminoides, 125 parts of agrimony and 75 parts of herba nonanthi;
group C: 35 parts of Senecio cannabifolius less, 66 parts of Japanese thistle herb, 65 parts of white mulberry root-bark, 55 parts of carbonized human hair, 57 parts of cacumen biotae, 28 parts of rhubarb and 66 parts of dwarf lilyturf tuber;
group D: 58 parts of callicarpa bodinieri, 85 parts of clinopodium polycephalum, 57 parts of euphorbia hirta, 90 parts of schizonepeta charcoal, 57 parts of cattail pollen charcoal and 85 parts of India madder root charcoal;
wherein, the weight ratio of the group A, the group B, the group C and the group D is 1: 1: 1: 1.
4. a method for preparing a traditional Chinese medicine formula for treating epistaxis in children according to any one of claims 1 to 3, which is characterized by comprising the following steps: the method comprises the following specific steps:
(1) weighing the raw materials according to the weight parts, uniformly mixing, and putting into a health preserving pot or a marmite for later use;
(2) adding water, soaking, decocting, and filtering to obtain filtrate.
5. The method for preparing a traditional Chinese medicine formula for treating epistaxis in children according to claim 4, which is characterized in that: the water adding amount in the step (2) is 5-8 times of the weight of the raw materials.
6. The method for preparing a traditional Chinese medicine formula for treating epistaxis in children according to claim 5, which is characterized in that: the water adding amount in the step (2) is 6 times of the weight of the raw materials.
7. The method for preparing a traditional Chinese medicine formula for treating epistaxis in children according to claim 4, which is characterized in that: the soaking time in the step (2) is 3-5 h.
8. The method for preparing a traditional Chinese medicine formula for treating epistaxis in children according to claim 7, which is characterized in that: the soaking time in the step (2) is 4 hours.
9. The method for preparing a traditional Chinese medicine formula for treating epistaxis in children according to claim 4, which is characterized in that: the decoction time in the step (2) is 1-2 h.
10. The method for preparing a traditional Chinese medicine formula for treating epistaxis in children according to claim 9, which is characterized in that: the decoction time in the step (2) is 1.5 h.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010420499.7A CN111529632A (en) | 2020-05-18 | 2020-05-18 | Traditional Chinese medicine formula for treating infantile epistaxis and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010420499.7A CN111529632A (en) | 2020-05-18 | 2020-05-18 | Traditional Chinese medicine formula for treating infantile epistaxis and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111529632A true CN111529632A (en) | 2020-08-14 |
Family
ID=71969391
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010420499.7A Pending CN111529632A (en) | 2020-05-18 | 2020-05-18 | Traditional Chinese medicine formula for treating infantile epistaxis and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111529632A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114533826A (en) * | 2022-02-23 | 2022-05-27 | 江志华 | Traditional Chinese medicine for treating infantile epistaxis and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101745041A (en) * | 2008-12-19 | 2010-06-23 | 宋慧婷 | Chinese medicine prescription for treating nosebleed |
CN102512598A (en) * | 2012-01-06 | 2012-06-27 | 马永波 | Medicinal composition for arresting bleeding and generating blood platelets |
CN106492007A (en) * | 2016-10-25 | 2017-03-15 | 马国坚 | A kind of formula that is cured the disease with Rhizoma Imperatae Chinese herbal medicine and decoction method |
-
2020
- 2020-05-18 CN CN202010420499.7A patent/CN111529632A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101745041A (en) * | 2008-12-19 | 2010-06-23 | 宋慧婷 | Chinese medicine prescription for treating nosebleed |
CN102512598A (en) * | 2012-01-06 | 2012-06-27 | 马永波 | Medicinal composition for arresting bleeding and generating blood platelets |
CN106492007A (en) * | 2016-10-25 | 2017-03-15 | 马国坚 | A kind of formula that is cured the disease with Rhizoma Imperatae Chinese herbal medicine and decoction method |
Non-Patent Citations (3)
Title |
---|
李凡成: "桑白皮饮治疗鼻衄64例", 《湖南中医学院学报》 * |
皱百仓: "自拟鼻衄汤治疗鼻出血40例疗效观察", 《甘肃中医学院学报》 * |
蒋中晋: "中医治疗鼻病7法", 《江苏中医药》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114533826A (en) * | 2022-02-23 | 2022-05-27 | 江志华 | Traditional Chinese medicine for treating infantile epistaxis and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105012392A (en) | Traditional Chinese medicine composition for treating rhinitis and preparation method thereof | |
CN102205026A (en) | Chinese medicinal composition for treating children chronic sinusitis and preparation method thereof | |
WO2012139314A1 (en) | Chinese herbal medicinal composition for treating cancer | |
CN101884776A (en) | Chinese preparation for treating hand-foot-and-mouth diseases | |
CN104784548A (en) | Traditional Chinese medicine composition for treating cough and application thereof | |
CN115770279B (en) | Traditional Chinese medicine composition for treating chronic lower limb vein diseases, decoction and preparation thereof | |
CN111529632A (en) | Traditional Chinese medicine formula for treating infantile epistaxis and preparation method thereof | |
CN104984148A (en) | Traditional Chinese medicine composite for wound care in clinical application | |
CN112717113B (en) | Traditional Chinese medicine composition for treating allergic rhinitis and paste formula and application thereof | |
CN101874850A (en) | Medicament for treating chronic urticaria | |
CN113750188B (en) | Application of traditional Chinese medicine composition in preparation of medicine for treating cold | |
CN113713009A (en) | Traditional Chinese medicine composition for improving specific endowment constitution and preparation method and application thereof | |
CN105250968A (en) | Traditional Chinese medicine preparation for treating asthma | |
CN102727791B (en) | Medicine for treating AIDS and preparation method thereof | |
CN105412877A (en) | Traditional Chinese medicine preparation for treating influenza and preparation method thereof | |
CN105362579A (en) | Traditional Chinese medicinal preparation for treating cold and preparation method of traditional Chinese medicinal preparation | |
CN104491448A (en) | Traditional Chinese medicine composition for treating prosopalgia caused by wind-heat attacking superficies | |
CN105194165B (en) | Traditional Chinese medicine used for treating infection of urinary system and preparation method thereof | |
CN103800869A (en) | Traditional Chinese medicine composition for treating anaphylactic rhinitis | |
CN102600285B (en) | Complex propolis composition for treating infectious atrophic rhinitis of pigs and preparation method thereof | |
CN106309684A (en) | Pill medicine for treating allergic rhinitis and preparation method thereof | |
CN107854682B (en) | Traditional Chinese medicine water preparation for treating sphagitis and preparation method thereof | |
CN104524296A (en) | Traditional Chinese medicine composition for treating summerheat-heat stirring wind syndrome pattern summerheat convulsive disease | |
CN104547359A (en) | Traditional Chinese medicine composition for treating spleen deficiency and dampness stagnation type eczema | |
CN115414451A (en) | A topical Chinese medicinal composition for treating acne, and its preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200814 |